SAFETY OF VACCINES CONTAINING MENINGOCOCCAL GROUP B POLYSACCHARIDE
- 21 July 1984
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 324 (8395) , 166
- https://doi.org/10.1016/s0140-6736(84)91083-3
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITISThe Lancet, 1983
- Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharideInfection and Immunity, 1983
- Measurement of antibodies to meningococcal group B polysaccharide: low avidity binding and equilibrium binding constants.The Journal of Immunology, 1982
- Complex of Meningococcal Group B Polysaccharide and Type 2 Outer Membrane Protein Immunogenic in ManJournal of Clinical Investigation, 1979
- Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model.The Journal of Experimental Medicine, 1976
- Immunochemical Similarity Between Polysaccharide Antigens of Escherichia Coli 07:K1(L):NM and Group B Neisseria MeningitidisThe Journal of Immunology, 1973